Alfred Sandrock - Feb 17, 2023 Form 4 Insider Report for Voyager Therapeutics, Inc. (VYGR)

Role: President and CEO, Director
Signature: /s/ Robert Hesslein, as Attorney-in-Fact for Alfred Sandrock
Stock symbol: VYGR
Transactions as of: Feb 17, 2023
Transactions value $: $0
Form type: 4
Date filed: 2/22/2023, 07:51 PM
Previous filing: Mar 23, 2022
Next filing: Apr 5, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	VYGR	Common Stock	Award	$0	+120K	+117.58%	$0.00	222K	Feb 17, 2023	Direct	F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	VYGR	Stock Option (Right to Buy)	Award	$0	+240K		$0.00	240K	Feb 17, 2023	Common Stock	240K	$7.43	Direct	F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Consists of shares of common stock issuable under an aggregate of 120,000 restricted stock units ("RSUs") awarded to the Reporting Person pursuant to the Voyager Therapeutics, Inc. 2015 Stock Option and Incentive Plan (the "Plan"). Each RSU represents the right to receive one share of common stock upon vesting. The vesting commencement date of the RSU award is the grant date, February 17, 2023. The RSU award vests over three years, with 1/3rd of the shares of common stock underlying the RSU award vesting on the one-year anniversary of such vesting commencement date and an additional 1/3rd of the shares of common stock underlying the RSU award vesting at the end of each successive one-year period thereafter, subject to the Reporting Person's continued service.
F2	Includes 2,055 shares of common stock acquired under the Voyager Therapeutics, Inc. 2015 Employee Stock Purchase Plan on December 31, 2022.
F3	This stock option was issued pursuant to the Plan. The vesting commencement date of the option is the grant date, February 17, 2023. The option vests over four years, with 1/48th of the shares of common stock underlying the option vesting upon the one-month anniversary of such vesting commencement date and an additional 1/48th of the shares of common stock underlying the option vesting at the end of each successive one-month period thereafter, subject to the Reporting Person's continued service.